A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
variceal 13 21 13 21 B-chronic_disease
bleeding 22 30 22 30 I-chronic_disease
where 31 36 31 36 O
the 37 40 37 40 O
varices 41 48 41 48 O
have 49 53 49 53 O
not 54 57 54 57 O
been 58 62 58 62 O
eradicated 63 73 63 73 O
or 74 76 74 76 O
decompressed 77 89 77 89 O
by 90 92 90 92 O
shunt 93 98 93 98 O
placement 99 108 99 108 O

A 0 1 109 110 O
life 2 6 111 115 B-clinical_variable
expectancy 7 17 116 126 I-clinical_variable
of 18 20 127 129 O
at 21 23 130 132 O
least 24 29 133 138 O
6 30 31 139 140 B-lower_bound
months 32 38 141 147 I-lower_bound
with 39 43 148 152 O
a 44 45 153 154 O
Karnofsky 46 55 155 164 B-clinical_variable
performance 56 67 165 176 I-clinical_variable
status 68 74 177 183 I-clinical_variable
of 75 77 184 186 O
at 78 80 187 189 O
least 81 86 190 195 O
70 87 89 196 198 B-lower_bound

Cirrhotic 0 9 199 208 B-clinical_variable
status 10 16 209 215 I-clinical_variable
of 17 19 216 218 I-clinical_variable
Child 20 25 219 224 I-clinical_variable
- 25 26 224 225 I-clinical_variable
Pugh 26 30 225 229 I-clinical_variable
class 31 36 230 235 I-clinical_variable
A 37 38 236 237 I-clinical_variable
or 39 41 238 240 I-clinical_variable
B 42 43 241 242 I-clinical_variable

Extensive 0 9 243 252 O
liver 10 15 253 258 B-cancer
tumor 16 21 259 264 I-cancer
burden 22 28 265 271 I-cancer
, 28 29 271 272 O
defined 30 37 273 280 O
as 38 40 281 283 O
more 41 45 284 288 O
than 46 50 289 293 O
75 51 53 294 296 B-lower_bound
% 53 54 296 297 I-lower_bound
of 55 57 298 300 O
the 58 61 301 304 O
liver 62 67 305 310 O

History 0 7 311 318 O
of 8 10 319 321 O
an 11 13 322 324 O
active 14 20 325 331 O
connective 21 31 332 342 B-chronic_disease
tissue 32 38 343 349 I-chronic_disease
disorder 39 47 350 358 I-chronic_disease

Male 0 4 359 363 B-gender

Must 0 4 364 368 O
be 5 7 369 371 O
aware 8 13 372 377 O
of 14 16 378 380 O
the 17 20 381 384 O
neoplastic 21 31 385 395 O
nature 32 38 396 402 O
of 39 41 403 405 O
his 42 45 406 409 O
/ 45 46 409 410 O
her 46 49 410 413 O
disease 50 57 414 421 O
and 58 61 422 425 O
willingly 62 71 426 435 O
provide 72 79 436 443 O
written 80 87 444 451 O
, 87 88 451 452 O
informed 89 97 453 461 O
consent 98 105 462 469 O
after 106 111 470 475 O
being 112 117 476 481 O
informed 118 126 482 490 O
of 127 129 491 493 O
the 130 133 494 497 O
procedure 134 143 498 507 O
to 144 146 508 510 O
be 147 149 511 513 O
followed 150 158 514 522 O
, 158 159 522 523 O
the 160 163 524 527 O
experimental 164 176 528 540 O
nature 177 183 541 547 O
of 184 186 548 550 O
the 187 190 551 554 O
therapy 191 198 555 562 B-treatment
, 198 199 562 563 O
alternatives 200 212 564 576 O
, 212 213 576 577 O
potential 214 223 578 587 O
benefits 224 232 588 596 O
, 232 233 596 597 O
side 234 238 598 602 O
- 238 239 602 603 O
effects 239 246 603 610 O
, 246 247 610 611 O
risks 248 253 612 617 O
and 254 257 618 621 O
discomforts 258 269 622 633 O

Myocardial 0 10 634 644 B-chronic_disease
infarction 11 21 645 655 I-chronic_disease
more 22 26 656 660 O
than 27 31 661 665 O
6 32 33 666 667 B-lower_bound
months 34 40 668 674 I-lower_bound
prior 41 46 675 680 I-lower_bound
to 47 49 681 683 O
study 50 55 684 689 O
entry 56 61 690 695 O

No 0 2 696 698 O
prior 3 8 699 704 O
radiotherapy 9 21 705 717 B-treatment
to 22 24 718 720 O
the 25 28 721 724 O
upper 29 34 725 730 O
abdomen 35 42 731 738 O

Other 0 5 739 744 O
baseline 6 14 745 753 O
labs 15 19 754 758 O
must 20 24 759 763 O
meet 25 29 764 768 O
the 30 33 769 772 O
following 34 43 773 782 O
criteria 44 52 783 791 O
: 52 53 791 792 O
total 54 59 793 798 O
bilirubin 60 69 799 808 B-clinical_variable
< 70 71 809 810 O
3mg 72 75 811 814 B-upper_bound
/ 75 76 814 815 I-upper_bound
dl 76 78 815 817 I-upper_bound
, 78 79 817 818 O
albumin 80 87 819 826 B-clinical_variable
> 87 88 826 827 O
2.5mg 89 94 828 833 B-lower_bound
/ 94 95 833 834 I-lower_bound
dl 95 97 834 836 I-lower_bound
, 97 98 836 837 O
and 99 102 838 841 O
liver 103 108 842 847 B-clinical_variable
enzymes 109 116 848 855 I-clinical_variable
less 117 121 856 860 O
than 122 126 861 865 O
three 127 132 866 871 B-upper_bound
times 133 138 872 877 I-upper_bound
the 139 142 878 881 I-upper_bound
upper 143 148 882 887 I-upper_bound
limit 149 154 888 893 I-upper_bound
of 155 157 894 896 I-upper_bound
normal 158 164 897 903 I-upper_bound
. 164 165 903 904 O
Creatinine 166 176 905 915 B-clinical_variable
must 177 181 916 920 O
also 182 186 921 925 O
be 187 189 926 928 O
< 190 191 929 930 O
1.8mg 192 197 931 936 B-upper_bound
/ 197 198 936 937 I-upper_bound
dl 198 200 937 939 I-upper_bound
or 201 203 940 942 O
a 204 205 943 944 O
creatinine 206 216 945 955 B-clinical_variable
clearance 217 226 956 965 I-clinical_variable
> 227 228 966 967 O
50ml 229 233 968 972 B-upper_bound
/ 233 234 972 973 I-upper_bound
min 234 237 973 976 I-upper_bound

Patient 0 7 977 984 O
's 7 9 984 986 O
will 10 14 987 991 O
have 15 19 992 996 O
no 20 22 997 999 O
evidence 23 31 1000 1008 O
of 32 34 1009 1011 O
gross 35 40 1012 1017 B-chronic_disease
vascular 41 49 1018 1026 I-chronic_disease
invasion 50 58 1027 1035 I-chronic_disease

Patients 0 8 1036 1044 O
can 9 12 1045 1048 O
have 13 17 1049 1053 O
extra 18 23 1054 1059 B-chronic_disease
- 23 24 1059 1060 I-chronic_disease
hepatic 24 31 1060 1067 I-chronic_disease
disease 32 39 1068 1075 I-chronic_disease
, 39 40 1075 1076 O
provided 41 49 1077 1085 O
the 50 53 1086 1089 O
hepatic 54 61 1090 1097 O
disease 62 69 1098 1105 O
is 70 72 1106 1108 O
the 73 76 1109 1112 O
highest 77 84 1113 1120 O
burden 85 91 1121 1127 O
, 91 92 1127 1128 O
the 93 96 1129 1132 O
extra 97 102 1133 1138 O
- 102 103 1138 1139 O
hepatic 103 110 1139 1146 O
disease 111 118 1147 1154 O
is 119 121 1155 1157 O
low 122 125 1158 1161 O
burden 126 132 1162 1168 O
and 133 136 1169 1172 O
potentially 137 148 1173 1184 O
treatable 149 158 1185 1194 O
with 159 163 1195 1199 O
surgery 164 171 1200 1207 B-treatment
, 171 172 1207 1208 O
ablative 173 181 1209 1217 B-treatment
radiation 182 191 1218 1227 I-treatment
therapy 192 199 1228 1235 I-treatment
, 199 200 1235 1236 O
or 201 203 1237 1239 O
US 204 206 1240 1242 O
Food 207 211 1243 1247 O
and 212 215 1248 1251 O
Drug 216 220 1252 1256 O
Administration 221 235 1257 1271 O
- 235 236 1271 1272 O
approved 236 244 1272 1280 O
first- 245 251 1281 1287 O
or 252 254 1288 1290 O
second 255 261 1291 1297 B-treatment
- 261 262 1297 1298 I-treatment
line 262 266 1298 1302 I-treatment
systemic 267 275 1303 1311 I-treatment
therapy 276 283 1312 1319 I-treatment
regimens 284 292 1320 1328 I-treatment

Patients 0 8 1329 1337 O
who 9 12 1338 1341 O
are 13 16 1342 1345 O
being 17 22 1346 1351 O
therapeutically 23 38 1352 1367 O
anticoagulated 39 53 1368 1382 O
with 54 58 1383 1387 O
an 59 61 1388 1390 O
agent 62 67 1391 1396 O
such 68 72 1397 1401 O
as 73 75 1402 1404 O
Coumadin 76 84 1405 1413 B-treatment
or 85 87 1414 1416 O
heparin 88 95 1417 1424 B-treatment
will 96 100 1425 1429 O
be 101 103 1430 1432 O
allowed 104 111 1433 1440 O
to 112 114 1441 1443 O
participate 115 126 1444 1455 O
provided 127 135 1456 1464 O
that 136 140 1465 1469 O
no 141 143 1470 1472 O
prior 144 149 1473 1478 O
evidence 150 158 1479 1487 O
of 159 161 1488 1490 O
underlying 162 172 1491 1501 O
abnormality 173 184 1502 1513 O
in 185 187 1514 1516 O
these 188 193 1517 1522 O
parameters 194 204 1523 1533 O
exists 205 211 1534 1540 O

Patients 0 8 1541 1549 O
will 9 13 1550 1554 O
have 14 18 1555 1559 O
no 19 21 1560 1562 O
more 22 26 1563 1567 O
than 27 31 1568 1572 O
3 32 33 1573 1574 B-upper_bound
distinct 34 42 1575 1583 O
lesions 43 50 1584 1591 B-clinical_variable
, 50 51 1591 1592 O
all 52 55 1593 1596 O
being 56 61 1597 1602 O
≤ 62 63 1603 1604 O
3 64 65 1605 1606 B-upper_bound
cm 65 67 1606 1608 I-upper_bound
in 68 70 1609 1611 I-upper_bound
greatest 71 79 1612 1620 I-upper_bound
dimension 80 89 1621 1630 I-upper_bound
, 89 90 1630 1631 O
OR 91 93 1632 1634 O
1 94 95 1635 1636 O
lesion 96 102 1637 1643 O
≤ 103 104 1644 1645 O
6 105 106 1646 1647 B-upper_bound
cm 106 108 1647 1649 I-upper_bound
in 109 111 1650 1652 I-upper_bound
greatest 112 120 1653 1661 I-upper_bound
dimension 121 130 1662 1671 I-upper_bound

Patients 0 8 1672 1680 O
with 9 13 1681 1685 O
hepatocellular 14 28 1686 1700 B-cancer
carcinoma 29 38 1701 1710 I-cancer
will 39 43 1711 1715 O
be 44 46 1716 1718 O
excluded 47 55 1719 1727 O
from 56 60 1728 1732 O
this 61 65 1733 1737 O
study 66 71 1738 1743 O

Patients 0 8 1744 1752 O
with 9 13 1753 1757 O
primary 14 21 1758 1765 B-cancer
tumor 22 27 1766 1771 I-cancer
histology 28 37 1772 1781 O
of 38 40 1782 1784 O
lymphoma 41 49 1785 1793 B-cancer
, 49 50 1793 1794 O
leukemia 51 59 1795 1803 B-cancer
, 59 60 1803 1804 O
or 61 63 1805 1807 O
germ 64 68 1808 1812 B-cancer
cell 69 73 1813 1817 I-cancer
tumor 74 79 1818 1823 I-cancer

Platelet 0 8 1824 1832 B-clinical_variable
count 9 14 1833 1838 I-clinical_variable
≥ 15 16 1839 1840 O
60 17 19 1841 1843 B-lower_bound
x 20 21 1844 1845 I-lower_bound
109 22 25 1846 1849 I-lower_bound
/ 25 26 1849 1850 I-lower_bound
L 26 27 1850 1851 I-lower_bound
, 27 28 1851 1852 O
Hemoglobin 29 39 1853 1863 B-clinical_variable
≥ 40 41 1864 1865 O
8.5 42 45 1866 1869 B-lower_bound
g 46 47 1870 1871 I-lower_bound
/ 47 48 1871 1872 I-lower_bound
dL 48 50 1872 1874 I-lower_bound
, 50 51 1874 1875 O
WBC 52 55 1876 1879 B-clinical_variable
≥ 56 57 1880 1881 O
2000 58 62 1882 1886 B-lower_bound
/ 62 63 1886 1887 I-lower_bound
μL 63 65 1887 1889 I-lower_bound
International 66 79 1890 1903 B-clinical_variable
normalized 80 90 1904 1914 I-clinical_variable
ratio 91 96 1915 1920 I-clinical_variable
( 97 98 1921 1922 I-clinical_variable
INR 98 101 1922 1925 I-clinical_variable
) 101 102 1925 1926 I-clinical_variable
must 103 107 1927 1931 O
be 108 110 1932 1934 O
≤ 111 112 1935 1936 O
2.3 113 116 1937 1940 B-upper_bound

Portal 0 6 1941 1947 B-chronic_disease
vein 7 11 1948 1952 I-chronic_disease
occlusion 12 21 1953 1962 I-chronic_disease

Pregnant 0 8 1963 1971 B-pregnancy

Previous 0 8 1972 1980 B-treatment
systemic 9 17 1981 1989 I-treatment
chemotherapy 18 30 1990 2002 I-treatment
or 31 33 2003 2005 O
non 34 37 2006 2009 B-treatment
- 37 38 2009 2010 I-treatment
radiation 38 47 2010 2019 I-treatment
local 48 53 2020 2025 I-treatment
therapy 54 61 2026 2033 I-treatment
( 62 63 2034 2035 O
such 63 67 2035 2039 O
as 68 70 2040 2042 O
surgery 71 78 2043 2050 B-treatment
, 78 79 2050 2051 O
hepatic 80 87 2052 2059 B-treatment
arterial 88 96 2060 2068 I-treatment
therapy 97 104 2069 2076 I-treatment
, 104 105 2076 2077 O
chemoembolization 106 123 2078 2095 B-treatment
, 123 124 2095 2096 O
radiofrequency 125 139 2097 2111 B-treatment
ablation 140 148 2112 2120 I-treatment
, 148 149 2120 2121 O
percutaneous 150 162 2122 2134 B-treatment
ethanol 163 170 2135 2142 I-treatment
injection 171 180 2143 2152 I-treatment
or 181 183 2153 2155 O
cryoablation 184 196 2156 2168 B-treatment
) 196 197 2168 2169 O
is 198 200 2170 2172 O
allowed 201 208 2173 2180 O
. 208 209 2180 2181 O
The 210 213 2182 2185 O
lesion 214 220 2186 2192 O
must 221 225 2193 2197 O
however 226 233 2198 2205 O
have 234 238 2206 2210 O
shown 239 244 2211 2216 O
criteria 245 253 2217 2225 O
of 254 256 2226 2228 O
progression 257 268 2229 2240 O
based 269 274 2241 2246 O
on 275 277 2247 2249 O
RECIST 278 284 2250 2256 O
. 284 285 2256 2257 O
Local 286 291 2258 2263 B-treatment
therapy 292 299 2264 2271 I-treatment
must 300 304 2272 2276 O
be 305 307 2277 2279 O
completed 308 317 2280 2289 O
at 318 320 2290 2292 O
least 321 326 2293 2298 O
4 327 328 2299 2300 B-lower_bound
weeks 329 334 2301 2306 I-lower_bound
prior 335 340 2307 2312 I-lower_bound
to 341 343 2313 2315 O
the 344 347 2316 2319 O
baseline 348 356 2320 2328 O
scan 357 361 2329 2333 O
. 361 362 2333 2334 O
This 363 367 2335 2339 O
is 368 370 2340 2342 O
to 371 373 2343 2345 O
create 374 380 2346 2352 O
a 381 382 2353 2354 O
safer 383 388 2355 2360 O
treatment 389 398 2361 2370 B-treatment
environment 399 410 2371 2382 O
and 411 414 2383 2386 O
to 415 417 2387 2389 O
help 418 422 2390 2394 O
determine 423 432 2395 2404 O
the 433 436 2405 2408 O
effect 437 443 2409 2415 O
of 444 446 2416 2418 O
treatment 447 456 2419 2428 O
by 457 459 2429 2431 O
SBRT 460 464 2432 2436 B-treatment
alone 465 470 2437 2442 O
. 470 471 2442 2443 O
Patients 472 480 2444 2452 O
will 481 485 2453 2457 O
be 486 488 2458 2460 O
allowed 489 496 2461 2468 O
to 497 499 2469 2471 O
go 500 502 2472 2474 O
onto 503 507 2475 2479 O
appropriate 508 519 2480 2491 O
systemic 520 528 2492 2500 B-treatment
therapy 529 536 2501 2508 I-treatment
, 536 537 2508 2509 O
as 538 540 2510 2512 O
determined 541 551 2513 2523 O
by 552 554 2524 2526 O
their 555 560 2527 2532 O
medical 561 568 2533 2540 O
oncologist 569 579 2541 2551 O
, 579 580 2551 2552 O
2 581 582 2553 2554 B-lower_bound
weeks 583 588 2555 2560 I-lower_bound
following 589 598 2561 2570 O
delivery 599 607 2571 2579 O
of 608 610 2580 2582 O
SBRT 611 615 2583 2587 O

Renal 0 5 2588 2593 B-chronic_disease
failure 6 13 2594 2601 I-chronic_disease
requiring 14 23 2602 2611 O
hemo- 24 29 2612 2617 B-treatment
or 30 32 2618 2620 I-treatment
peritoneal 33 43 2621 2631 I-treatment
dialysis 44 52 2632 2640 I-treatment

Substance 0 9 2641 2650 O
abuse 10 15 2651 2656 O
, 15 16 2656 2657 O
medical 17 24 2658 2665 B-chronic_disease
, 24 25 2665 2666 O
psychological 26 39 2667 2680 B-chronic_disease
or 40 42 2681 2683 O
social 43 49 2684 2690 B-chronic_disease
conditions 50 60 2691 2701 I-chronic_disease
that 61 65 2702 2706 O
may 66 69 2707 2710 O
interfere 70 79 2711 2720 O
with 80 84 2721 2725 O
the 85 88 2726 2729 O
patient 89 96 2730 2737 O
's 96 98 2737 2739 O
participation 99 112 2740 2753 O
in 113 115 2754 2756 O
the 116 119 2757 2760 O
study 120 125 2761 2766 O
or 126 128 2767 2769 O
evaluation 129 139 2770 2780 O
of 140 142 2781 2783 O
the 143 146 2784 2787 O
study 147 152 2788 2793 O
results 153 160 2794 2801 O

The 0 3 2802 2805 O
target 4 10 2806 2812 O
lesion(s 11 19 2813 2821 O
) 19 20 2821 2822 O
can 21 24 2823 2826 O
be 25 27 2827 2829 O
accurately 28 38 2830 2840 O
measured 39 47 2841 2849 O
in 48 50 2850 2852 O
at 51 53 2853 2855 O
least 54 59 2856 2861 O
one 60 63 2862 2865 B-lower_bound
dimension 64 73 2866 2875 O
according 74 83 2876 2885 O
to 84 86 2886 2888 O
RECIST 87 93 2889 2895 O
and 94 97 2896 2899 O
must 98 102 2900 2904 O
have 103 107 2905 2909 O
a 108 109 2910 2911 O
maximum 110 117 2912 2919 B-clinical_variable
tumor 118 123 2920 2925 I-clinical_variable
volume 124 130 2926 2932 I-clinical_variable
of 131 133 2933 2935 O
≤ 134 135 2936 2937 O
100 136 139 2938 2941 B-upper_bound
cm3 140 143 2942 2945 I-upper_bound

Uncontrolled 0 12 2946 2958 O
inter 13 18 2959 2964 B-chronic_disease
- 18 19 2964 2965 I-chronic_disease
current 19 26 2965 2972 I-chronic_disease
illness 27 34 2973 2980 I-chronic_disease
including 35 44 2981 2990 O
, 44 45 2990 2991 O
but 46 49 2992 2995 O
not 50 53 2996 2999 O
limited 54 61 3000 3007 O
to 62 64 3008 3010 O
ongoing 65 72 3011 3018 O
or 73 75 3019 3021 O
active 76 82 3022 3028 B-chronic_disease
infection 83 92 3029 3038 I-chronic_disease
( 93 94 3039 3040 O
> 94 95 3040 3041 O
grade 96 101 3042 3047 B-lower_bound
2 102 103 3048 3049 I-lower_bound
National 104 112 3050 3058 O
Cancer 113 119 3059 3065 O
Institute 120 129 3066 3075 O
[ 130 131 3076 3077 O
NCI]-Common 131 142 3077 3088 O
Terminology 143 154 3089 3100 I-clinical_variable
Criteria 155 163 3101 3109 I-clinical_variable
for 164 167 3110 3113 I-clinical_variable
Adverse 168 175 3114 3121 I-clinical_variable
Events 176 182 3122 3128 I-clinical_variable
[ 183 184 3129 3130 I-clinical_variable
CTCAE 184 189 3130 3135 I-clinical_variable
] 189 190 3135 3136 I-clinical_variable
version 191 198 3137 3144 O
4.0 199 202 3145 3148 O
) 202 203 3148 3149 O
, 203 204 3149 3150 O
congestive 205 215 3151 3161 B-chronic_disease
heart 216 221 3162 3167 I-chronic_disease
failure 222 229 3168 3175 I-chronic_disease
( 230 231 3176 3177 O
> 231 232 3177 3178 O
New 233 236 3179 3182 B-clinical_variable
York 237 241 3183 3187 I-clinical_variable
Heart 242 247 3188 3193 I-clinical_variable
Association 248 259 3194 3205 I-clinical_variable
( 260 261 3206 3207 I-clinical_variable
NYHA 261 265 3207 3211 I-clinical_variable
) 265 266 3211 3212 I-clinical_variable
class 267 272 3213 3218 B-lower_bound
2 273 274 3219 3220 I-lower_bound
) 274 275 3220 3221 O
, 275 276 3221 3222 O
active 277 283 3223 3229 O
coronary 284 292 3230 3238 B-chronic_disease
artery 293 299 3239 3245 I-chronic_disease
disease 300 307 3246 3253 I-chronic_disease
( 308 309 3254 3255 I-chronic_disease
CAD 309 312 3255 3258 I-chronic_disease
) 312 313 3258 3259 I-chronic_disease
, 313 314 3259 3260 O
cardiac 315 322 3261 3268 B-chronic_disease
arrhythmias 323 334 3269 3280 I-chronic_disease
requiring 335 344 3281 3290 O
anti 345 349 3291 3295 B-treatment
- 349 350 3295 3296 I-treatment
arrhythmic 350 360 3296 3306 I-treatment
therapy 361 368 3307 3314 I-treatment
other 369 374 3315 3320 O
than 375 379 3321 3325 O
beta 380 384 3326 3330 B-treatment
blockers 385 393 3331 3339 I-treatment
or 394 396 3340 3342 O
digoxin 397 404 3343 3350 B-treatment
) 404 405 3350 3351 O
, 405 406 3351 3352 O
uncontrolled 407 419 3353 3365 B-chronic_disease
hypertension 420 432 3366 3378 I-chronic_disease
and 433 436 3379 3382 O
any 437 440 3383 3386 O
condition 441 450 3387 3396 O
which 451 456 3397 3402 O
could 457 462 3403 3408 O
jeopardize 463 473 3409 3419 O
the 474 477 3420 3423 O
safety 478 484 3424 3430 O
of 485 487 3431 3433 O
the 488 491 3434 3437 O
patient 492 499 3438 3445 O
and 500 503 3446 3449 O
his 504 507 3450 3453 O
/ 507 508 3453 3454 O
her 508 511 3454 3457 O
compliance 512 522 3458 3468 O
in 523 525 3469 3471 O
the 526 529 3472 3475 O
study 530 535 3476 3481 O

female 0 6 3482 3488 B-gender

patients 0 8 3489 3497 O
≥ 9 10 3498 3499 O
18 11 13 3500 3502 B-lower_bound
years 14 19 3503 3508 I-lower_bound
of 20 22 3509 3511 O
age 23 26 3512 3515 B-age

